Order Article Reprints

Loisios-Konstantinidis I, Cristofoletti R, Jamei M, Turner D, Dressman J. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen. Pharmaceutics. 2020; 12(11):1049. https://doi.org/10.3390/pharmaceutics12111049

Loisios-Konstantinidis, Ioannis, Rodrigo Cristofoletti, Masoud Jamei, David Turner, and Jennifer Dressman. 2020. "Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen" Pharmaceutics 12, no. 11: 1049. https://doi.org/10.3390/pharmaceutics12111049

Loisios-Konstantinidis, I., Cristofoletti, R., Jamei, M., Turner, D., & Dressman, J. (2020). Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen. Pharmaceutics, 12(11), 1049. https://doi.org/10.3390/pharmaceutics12111049